1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Sepsis - Epidemiology Forecast to 2030

Sepsis - Epidemiology Forecast to 2030

  • May 2021
  • 108 pages
  • ID: 6071727
  • Format: PDF
  • Delve Insight


Table of Contents

‘Sepsis—Epidemiology Forecast–2030’ report delivers an in-depth understanding of the Sepsis , historical and forecasted epidemiology as well as the Sepsis trends in the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan.

Sepsis Disease Understanding
As per the Sepsis Alliance, Sepsis is the body’s overwhelming and life-threatening response to infection that can lead to tissue damage, organ failure, and death.
In the past, septicemia, blood poisoning, and other vague terminology, meaning different things to different people, were used frequently, hampering attempts to identify septic patients properly. In 1991, a consensus conference developed definitions of Sepsis that linked infection with a systemic inflammatory response—the systemic inflammatory response syndrome (SIRS)—which was defined using simple clinical and laboratory parameters. Although Sepsis detection was challenging, the definition of SIRS was rather unspecific since similar inflammatory responses were seen as part of the physiological response to noninfectious insults, such as surgery and pancreatitis. Besides, the SIRS criteria performed poorly in identifying patients who required critical care and who had significant morbidity and mortality.
These issues led to a recent new consensus definition for Sepsis and Septic shock. This international task force defined Sepsis as ‘life-threatening organ dysfunction caused by a dysregulated host response to infection.’ The United States has not adopted these definitions since they have not been tested prospectively. All of the research and improvement in mortality has been based on utilization of the SEP-2 definitions that have been used since 1992 (in all of the clinical research as well as in clinical practice) and its associated screening and early management bundles. One of the greatest concerns is that waiting till the organ dysfunction before intervening makes it harder to treat and more likely to have poor outcomes.
Continued in the report…..
Sepsis Epidemiology Perspective
The disease epidemiology covered in the report provides historical as well as forecasted epidemiology segmented by Total Incident Cases of Sepsis, Gender-Specific Incident Cases of Sepsis, Severity-Specific Incident Cases of Sepsis, Origin-Specific Incident Cases of Sepsis scenario in the 7MM covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom) and Japan from 2018 to 2030.

Sepsis Detailed Epidemiology Segmentation
• In 2020, the total estimated Incident Cases of Sepsis were 3,400,940 cases in the 7MM, which is expected to increase in the forecast period.
• US is the major contributor (55.01%, in 2020) to the incident population of Sepsis in the 7MM, with 1,870,897 cases.
• Out of EU5 countries, Germany had the highest incident cases in 2020 followed by the UK and Spain. France accounted for the least number of cases in 2020.
• Assessments indicate that lung infection, UTI infection, gut infection, and skin infection are the leading four infection sites in patients with Sepsis, accounting for 35%, 25%, 11%, and 11% of all sites of infection, respectively in the United States in 2020. In 2020, there were 654,814, 467,724, 205,799, and 205,799 Sepsis cases due to lung infection followed by UTI, gut infection, and skin infection in the US.
• In 2020, there were 1,066,411 cases of Sepsis without organ dysfunction followed by severe Sepsis and septic shock, accounting for 18.4% and 24.6% of the total cases respectively in the US.
“From several epidemiology studies, it was observed that the disease is more common in males as compared to females, but this trend is opposite in the US. In EU, and Japan, 50–65% of sepsis cases are contributed by males, and 35–50% of the cases are contributed by females. But in the US, around 49% of the cases are of males, and 51% are of females. Additionally, There are several infections that lead to sepsis, but it has been seen that lung infection, UTI infection, gut infection, and skin infection were the leading four infection sites in patients with sepsis.”

Scope of the Report
• The report covers the descriptive overview of Sepsis, explaining its causes, symptoms, pathophysiology, and genetic basis.
• The report provides insight into the 7MM historical and forecasted patient pool covering the United States, EU5 countries (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
• The report assesses the disease risk and burden and highlights the unmet needs of Sepsis.
• The report helps to recognize the growth opportunities in the 7MM with respect to the patient population.
• The report provides the segmentation of the disease epidemiology for 7MM by Total Incident Cases of Sepsis, Gender-specific Incident Cases of Sepsis, Severity-specific Incident Cases of Sepsis, Origin-specific Incident Cases of Sepsis.

Report Highlights
• 10-Year Forecast of Sepsis
• 7MM Coverage
• Total Incident Cases of Sepsis
• Male and Female Cases of Sepsis
• Sepsis Patients among different age groups

Key Questions Answered
• What are the disease risk, and burden of Sepsis ?
• What is the historical Sepsis patient pool in the United States, EU5 (Germany, France, Italy, Spain, and the UK), and Japan?
• What would be the forecasted patient pool of Sepsis at the 7MM level?
• What will be the growth opportunities across the 7MM with respect to the patient population pertaining to Sepsis ?
• Out of the above-mentioned countries, which country would have the highest incident population of Sepsis during the forecast period (2021–2030)?
• At what CAGR the population is expected to grow across the 7MM during the forecast period (2021–2030)?

Reasons to buy
The Sepsis report will allow the user to -
• Develop business strategies by understanding the trends shaping and driving the 7MM Sepsis epidemiology forecast.
• The Sepsis epidemiology report and model were written and developed by Masters and Ph.D. level epidemiologists.
• The Sepsis epidemiology model developed is easy to navigate, interactive with dashboards, and epidemiology based on transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over the 10-year forecast period using reputable sources.

Key Assessments
• Patient Segmentation
• Disease Risk and Burden
• Risk of disease by the segmentation
• Factors driving growth in a specific patient population

Geographies Covered
• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan
Study Period: 2018–2030

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Heparin-Induced Thrombocytopenia Testing in 90 Countries—Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation

  • $ 3850
  • September 2021
  • 1 pages

Heparin-Induced Thrombocytopenia Testing in 90 Countries-Five-Year Volume and Sales Forecasts, Supplier Sales and Shares, Competitive Analysis, Diagnostic Assays and Instrumentation This report is available ...

  • Europe
  • Northern Europe
  • Blood Disease
  • Diagnostics
  • Industry analysis


Reportlinker.com © Copyright 2022. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on